Adpt stock price target

The 4 analysts offering 12-month price forecasts for Adaptive Biotechnologies The current consensus among 6 polled investment analysts is to Buy stock in� Find the latest Adaptive Biotechnologies Corpor (ADPT) stock quote, history, news and Here's What Analysts Are Forecasting For Adaptive Biotechnologies � ADPT | Complete Adaptive Biotechnologies Corp. stock news by Adaptive Biotechnologies started at overweight with $45 stock price target at J.P. Morgan. Jul.

ADPT. Real-time BATS EXCHANGE - 02/26 04:00:01 pm. 29.92USD. -0.27%. Consensus Loading Target Price consensus revisions : last 18 months. Currently unprofitable and not forecast to become profitable over the next 3 years Stable Share Price: ADPT's share price has been volatile over the past 3 months Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Shares Recently? There may be differences between the Equity Summary Score analyst count and the number of underlying analysts listed. Due to the timing in receiving ratings� Current Technical Analysis and interactive chart for $ADPT stock / shares. Feb 29, Here's What Analysts Are Forecasting For Adaptive Biotechnologies� ADPT, Adaptive Biotechnologies - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. Information about which ETFs are holding the stock ADPT, Adaptive 1/23 - 8:54 PM, Adaptive Announces Pricing of Public Offering of Common Stock.

12 Mar 2020 Many individual analysts and firms give their ratings on a stock. While Looking ahead of 52-week period, the mean Target Price set by analysts is�

Stock analysis for Adaptive Biotechnologies Corp (ADPT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the latest Adaptive Biotechnologies Corporation ADPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Adaptive Biotechnologies Corporation - ADPT - Stock Price Today Get breaking news and analysis on Adaptive Biotechnologies Corporation (ADPT) stock, price quote and chart, trading and investing tools. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Real time Adeptus Health (ADPT) stock price quote, stock graph, news & analysis. Real time Adeptus Health (ADPT) stock price quote, stock graph, news & analysis. Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. Adaptimmune Therapeutics price target cut to $9 from $12 at SunTrust Robinson Humphrey Jun. 28, 2019 at 8:01 a.m. ET by Tonya Garcia Adaptimmune's stock tumbles after cancer study results prompts

3 days ago The stock currently trades at $19.70 and analysts tracking its performance over the next 12 months have a consensus estimate price target of�

1y Target Est 27.50 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate.

1y Target Est 185.29 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate.

Adaptimmune Therapeutics price target cut to $9 from $12 at SunTrust Robinson Humphrey Jun. 28, 2019 at 8:01 a.m. ET by Tonya Garcia Adaptimmune's stock tumbles after cancer study results prompts Find the latest Earnings Report Date for Adaptive Biotechnologies Corporation Common Stock (ADPT) at Nasdaq.com. Looking for additional market data? and may be an indicator of future price 1y Target Est 27.50 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. 1y Target Est 185.29 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Aurora Cannabis Inc. Common Shares (ACB) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

The 4 analysts offering 12-month price forecasts for Adaptive Biotechnologies The current consensus among 6 polled investment analysts is to Buy stock in�

Find the latest Earnings Report Date for Adaptive Biotechnologies Corporation Common Stock (ADPT) at Nasdaq.com. Looking for additional market data? and may be an indicator of future price 1y Target Est 27.50 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. 1y Target Est 185.29 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Aurora Cannabis Inc. Common Shares (ACB) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

1y Target Est 27.50 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. 1y Target Est 185.29 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Aurora Cannabis Inc. Common Shares (ACB) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Get the smart helping hand you always wished for. Shop Target for smart assistants at great prices. Free shipping on orders $35+ or free same-day pickup in store.